Molecular modeling study on tunnel behavior in different histone deacetylase isoforms

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Histone deacetylases (HDACs) are key epigenetic regulators and therapeutic targets for diseases like cancer.
• Developing isoform-selective HDAC inhibitors is difficult due to conserved active site structures.

Purpose of the Study:

• To analyze the tunnel structures of HDAC8, HDAC10, and HDAC11 using molecular dynamics simulations.
• To identify conserved amino acids within the active site tunnels for selective inhibitor design.
• To investigate the impact of specific amino acid mutations on tunnel conformation in HDAC11.

Main Methods:

• Molecular dynamics simulations were employed to study the active site tunnels of HDAC8, HDAC10, and HDAC11.
• Identification of conserved tunnel-forming amino acids across the three HDAC isoforms.
• Site-directed mutagenesis was performed on HDAC11 to mimic residues found in HDAC8 and HDAC10.

Main Results:

• Conserved amino acids forming the active site tunnels were identified across HDAC8, HDAC10, and HDAC11.
• A key difference was noted at one position: methionine in HDAC8, glutamic acid in HDAC10, and leucine in HDAC11.
• Mutating HDAC11 to mimic HDAC8 (L268M) maintained a deep, narrow tunnel, while mimicking HDAC10 (L268E) resulted in a wider, shallower tunnel.

Conclusions:

• Subtle differences in single amino acids significantly alter HDAC active site tunnel dimensions.
• These findings provide a basis for designing isoform-selective HDAC inhibitors.
• Targeting these structural variations can lead to more effective and specific cancer therapies.